Harm Reduction Group Reports Third Quarter 2024 Earnings

Simply Wall St

November 30, 2024

Harm Reduction Group (NGM:NOHARM) Third Quarter 2024 Results

Key Financial Results

Revenue: kr31.1m (down 32% from 3Q 2023).
Net loss: kr9.54m (loss widened by 131% from 3Q 2023).

earnings-and-revenue-history — NGM:NOHARM Earnings and Revenue History November 30th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Harm Reduction Group's share price is broadly unchanged from a week ago.

Risk Analysis

Don't forget that there may still be risks. For instance, we've identified 4 warning signs for Harm Reduction Group that you should be aware of.

The New Payments ETF Is Live on NASDAQ:

Money is moving to real-time rails, and a newly listed ETF now gives investors direct exposure. Fast settlement. Institutional custody. Simple access.

Explore how this launch could reshape portfolios

Valuation is complex, but we're here to simplify it.

Discover if Harm Reduction Group might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.